Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00554411 · ClinicalTrials.gov registry record
Assessing Ocular Surface Changes After Changing Glaucoma Medications
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 22
- Enrollment target
NCT00554411: Completed study, sponsored by University of Colorado, Denver.
NCT00554411 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00554411 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
Hypothesis: Changing to Travatan Z therapy increases the tear film break up time of subjects on Xalatan therapy presenting with ocular surface disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2007-11 |
| Est. Completion | 2011-08 |
What the finished NCT00554411 record still lists
NCT00554411 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00554411 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00554411 about?
NCT00554411 is a clinical study titled "Assessing Ocular Surface Changes After Changing Glaucoma Medications". Hypothesis: Changing to Travatan Z therapy increases the tear film break up time of subjects on Xalatan therapy presenting with ocular surface disease.
What is the current status of trial NCT00554411?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2007-11. Estimated completion is 2011-08.
Who is sponsoring clinical trial NCT00554411?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia